189 related articles for article (PubMed ID: 15456732)
1. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
Chami F; Chami N; Bennis S; Trouillas J; Remmal A
J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
[TBL] [Abstract][Full Text] [Related]
2. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
[TBL] [Abstract][Full Text] [Related]
3. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats.
Chami N; Chami F; Bennis S; Trouillas J; Remmal A
Braz J Infect Dis; 2004 Jun; 8(3):217-26. PubMed ID: 15476054
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
5. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
[TBL] [Abstract][Full Text] [Related]
6. Acute vaginal candidosis model in the immunocompromized rat to evaluate delivery systems for antimycotics.
Foldvari M; Radhi J; Yang G; He Z; Rennie R; Wearley L
Mycoses; 2000; 43(11-12):393-401. PubMed ID: 11204356
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Zhang H; Wang K; Zhang G; Ho HI; Gao A
Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
[TBL] [Abstract][Full Text] [Related]
9. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
10. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
11. Candida albicans: the estrogen target for vaginal colonization.
Tarry W; Fisher M; Shen S; Mawhinney M
J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
[TBL] [Abstract][Full Text] [Related]
12. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans.
Braga PC; Sasso MD; Culici M; Alfieri M
Fitoterapia; 2007 Sep; 78(6):396-400. PubMed ID: 17590533
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis.
de Freitas Araújo MG; Pacífico M; Vilegas W; Dos Santos LC; Icely PA; Miró MS; Scarpa MV; Bauab TM; Sotomayor CE
Med Mycol; 2013 Oct; 51(7):673-82. PubMed ID: 23758104
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
Liao H; Liu S; Wang H; Su H; Liu Z
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
[TBL] [Abstract][Full Text] [Related]
16. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment.
Ventolini G; Baggish MS
Maturitas; 2005 Jul; 51(3):294-8. PubMed ID: 15978973
[TBL] [Abstract][Full Text] [Related]
17. Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
Peeters F; Snauwaert R; Segers J; Van Cutsem J; Amery W
Arzneimittelforschung; 1973 Aug; 23(8):1107-11. PubMed ID: 4588098
[No Abstract] [Full Text] [Related]
18. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
19. Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis.
Sosto F; Benvenuti C;
Arzneimittelforschung; 2011; 61(2):126-31. PubMed ID: 21428248
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis.
Andrade JT; Fantini de Figueiredo G; Cruz LF; Eliza de Morais S; Souza CDF; Pinto FCH; Ferreira JMS; Araújo MGF
Rev Iberoam Micol; 2019; 36(4):192-199. PubMed ID: 31757595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
